(19)
(11) EP 2 968 726 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.12.2020 Bulletin 2020/53

(45) Mention of the grant of the patent:
21.10.2020 Bulletin 2020/43

(21) Application number: 14714551.0

(22) Date of filing: 13.03.2014
(51) International Patent Classification (IPC): 
A61M 1/34(2006.01)
A61M 1/28(2006.01)
 A61M 1/16(2006.01)
(86) International application number:
PCT/US2014/025469
(87) International publication number:
WO 2014/151322 (25.09.2014 Gazette 2014/39)

(54)

UNIVERSAL PORTABLE MACHINE FOR ONLINE HEMODIAFILTRATION USING REGENERATED DIALYSATE

UNIVERSELLE TRAGBARE MASCHINE ZUR ONLINE-HÄMODIAFILTRATION MIT EINEM REGENERIERTEN DIALYSAT

MACHINE PORTABLE UNIVERSELLE POUR HÉMODIAFILTRATION EN LIGNE À L'AIDE D'UN DIALYSAT RÉGÉNÉRÉ

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 14.03.2013 US 201313828240

(43) Date of publication of application:
20.01.2016 Bulletin 2016/03

(60) Divisional application:
20199210.4

(73) Proprietor: Fresenius Medical Care Holdings, Inc.
Waltham, MA 02451-1457 (US)

(72) Inventors:
  • UPDYKE, Palmer, David
    Lake Forest, CA 92630 (US)
  • FULKERSON, Barry
    Lake Forest, CA 92630 (US)
  • DE LEON DE LEON, Amaury
    Lake Forest, CA 92630 (US)
  • BAYLY, Michelle
    Lake Forest, CA 92630 (US)

(74) Representative: Croce, Valeria et al
Jacobacci & Partners S.p.A. Piazza della Vittoria, 11
25122 Brescia
25122 Brescia (IT)


(56) References cited: : 
EP-A2- 0 771 569
US-A1- 2006 226 086
US-A1- 2012 204 968
 US-A1- 2005 131 331
US-A1- 2011 303 588
US-B1- 6 187 207
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).